COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit
Andrea Gilioli(University of Modena and Reggio Emilia), Angela Cuoghi(University of Modena and Reggio Emilia), Corrado Colasante(University of Modena and Reggio Emilia), Mario Luppi(University of Modena and Reggio Emilia), Monica Pecorari(University of Modena and Reggio Emilia), Monica Morselli(University of Modena and Reggio Emilia), Elisabetta Colaci(University of Modena and Reggio Emilia), Valeria Pioli(University of Modena and Reggio Emilia), Davide Giusti(University of Modena and Reggio Emilia), Erica Franceschini(University of Modena and Reggio Emilia), Francesca Bettelli(Azienda Ospedaliero-Universitaria di Modena), Patrizia Comoli(Policlinico San Matteo Fondazione), Tommaso Trenti(Azienda Unita' Sanitaria Locale Di Modena), Paola Bresciani(Azienda Ospedaliero-Universitaria di Modena), William Gennari(University of Modena and Reggio Emilia), Roberto Marasca(University of Modena and Reggio Emilia), Cristina Mussini(University of Modena and Reggio Emilia), Leonardo Potenza(University of Modena and Reggio Emilia), Fabio Forghieri(Azienda Ospedaliero-Universitaria di Modena), Andrea Messerotti(University of Modena and Reggio Emilia), Anna Candoni(University of Udine)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998